Jarushka Naidoo (@drjnaidoo) 's Twitter Profile
Jarushka Naidoo

@drjnaidoo

Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins University

ID: 972549291867889666

linkhttps://scholar.google.com/citations?user=MSEo30cAAAAJ&hl=en calendar_today10-03-2018 19:06:35

5,5K Tweet

10,10K Followers

1,1K Following

Jarushka Naidoo (@drjnaidoo) 's Twitter Profile Photo
Jarushka Naidoo
@drjnaidoo

24 days ago

Final Analysis Ph I CHRYSALIS: Amivantamab in stage IV METexon14+ JTO & JTO CRR: - 97pts (1L=16; 2L=28, prior MET TKI=53) - ORR (all-comer) 32%, 50% in 1L, 19% prior MET TKI - mDOR 11.2m; mPFS 5.3m; mOS 15.8m - 79% rash, 72% IRRs OncoAlert #LCSM jto.org/article/S1556-…